TAF1 and hepatocellular carcinoma: Some data suggest that TAF1 may contribute to the progression of hepatocellular carcinoma (HCC) and is significantly associated with OS in patients with HCC (30, 31), but other studies have shown that inactivation of TAF1 may be involved in tumorigenesis (29).